About DxTerity
DxTerity is a company based in Los Angeles (United States) founded in 2006. DxTerity has raised $3.75 million across 7 funding rounds from investors including HHS. DxTerity operates in a competitive market with competitors including MedGenome, Foundation Medicine, ArcherDX, Personalis and Veritas Genetics, among others.
- Headquarter Los Angeles, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.75 M (USD)
in 7 rounds
-
Latest Funding Round
$100 K (USD), Series A
Jan 12, 2015
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of DxTerity
Unlock access to complete
Funding Insights of DxTerity
DxTerity has successfully raised a total of $3.75M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $100 thousand completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in DxTerity
DxTerity has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for DxTerity
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DxTerity
Investment portfolio details for DxTerity
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DxTerity
Detailed financials for DxTerity
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dxterity Comparisons
Peer comparison for DxTerity
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DxTerity
DxTerity operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MedGenome, Foundation Medicine, ArcherDX, Personalis and Veritas Genetics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| Locked | Locked | Locked |
Genetic testing products for health risks and traits are offered.
|
|
| Locked | Locked | Locked |
RNA-sequencing transcriptome kits for health data analysis are developed.
|
Detailed competitors of DxTerity
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dxterity
Complete news archive for DxTerity
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DxTerity
DxTerity was founded in 2006 and raised its 1st funding round 2 years after it was founded.
DxTerity is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
DxTerity is a funded company, having raised a total of $3.75M across 7 funding rounds to date.
DxTerity was founded in 2006 and is headquartered in Los Angeles, United States. Operations focus on the genomics sector, where direct-to-consumer, non-clinical genetic tests are developed and offered. Proprietary DxDirect chemistry, combined with RT-PCR, enables assay creation and gene signature analysis through the NEAT ligation process. Fingerstick blood samples are collected, stabilized using the DxCollect system, and shipped via US mail for processing.
DxTerity's top competitors include Foundation Medicine, MedGenome and Personalis.
DxTerity has 1 investor. Key investors include HHS.